Zions Bancorporation (NASDAQ: ZION) is one of 206 publicly-traded companies in the “Commercial Banks” industry, but how does it contrast to its rivals? We will compare Zions Bancorporation to similar companies based off the strength of its risk, institutional ownership, analyst recommendations, profitability, earnings, dividends and valuation.


Zions Bancorporation pays an annual dividend of $0.48 per share and has a dividend yield of 1.1%. Zions Bancorporation pays out 19.1% of its earnings in the form of a dividend. As a group, “Commercial Banks” companies pay a dividend yield of 1.9% and pay out 35.7% of their earnings in the form of a dividend.

Institutional and Insider Ownership

92.5% of Zions Bancorporation shares are owned by institutional investors. Comparatively, 47.4% of shares of all “Commercial Banks” companies are owned by institutional investors. 1.5% of Zions Bancorporation shares are owned by insiders. Comparatively, 11.9% of shares of all “Commercial Banks” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Zions Bancorporation and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zions Bancorporation 0 11 11 0 2.50
Zions Bancorporation Competitors 837 3903 2823 114 2.29

Zions Bancorporation presently has a consensus price target of $45.15, indicating a potential upside of 5.66%. All “Commercial Banks” companies have a potential upside of 6.43%. Given Zions Bancorporation’s rivals higher probable upside, analysts plainly believe Zions Bancorporation has less favorable growth aspects than its rivals.


This table compares Zions Bancorporation and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Zions Bancorporation 21.97% 8.14% 0.90%
Zions Bancorporation Competitors 19.77% 8.37% 0.88%

Valuation and Earnings

This table compares Zions Bancorporation and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Zions Bancorporation $2.46 billion N/A 17.02
Zions Bancorporation Competitors N/A N/A 23.74

Zions Bancorporation is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently the more affordable than other companies in its industry.

Risk and Volatility

Zions Bancorporation has a beta of 1.45, indicating that its stock price is 45% more volatile than the S&P 500. Comparatively, Zions Bancorporation’s rivals have a beta of 0.73, indicating that their average stock price is 27% less volatile than the S&P 500.


Zions Bancorporation beats its rivals on 8 of the 14 factors compared.

About Zions Bancorporation

Zions Bancorporation is a financial holding company. The Company conducts its banking operations through separately managed and branded segments, including Zions Bank, Amegy Bank, California Bank & Trust, National Bank of Arizona, Nevada State Bank (NSB), Vectra Bank Colorado, The Commerce Bank of Washington (TCBW) and Other. It focuses on providing community banking services through its business lines, including small and medium-sized business and corporate banking; commercial and residential development, construction and term lending; retail banking; treasury cash management and related products and services; residential mortgage servicing and lending; trust and wealth management; limited capital markets activities, including municipal finance advisory and underwriting, and investment activities. It provides a range of banking and related services, primarily in Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington and Wyoming.

Receive News & Stock Ratings for Zions Bancorporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zions Bancorporation and related stocks with our FREE daily email newsletter.